CHRISTINA ACKERMANN Insider Trading $BVF Bausch Health Companies Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CHRISTINA ACKERMANN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CHRISTINA ACKERMANN. CHRISTINA ACKERMANN is EVP and General Counsel in Valeant Pharmaceuticals International, Inc. ($BVF) and Director in GRAYBUG VISION, INC. ($GRAY).
CHRISTINA ACKERMANN in Bausch Health Companies Inc.
Trading Symbol: BVFIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CHRISTINA ACKERMANN: EVP and General Counsel
Holdings: 166,758 shares
Latest Transaction: Mar 15 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of CHRISTINA ACKERMANN in Bausch Health Companies Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 15 2021 | BVF | Bausch Health Comp ... | ACKERMANN CHRISTINA | EVP AND GENERAL COU ... | Payment of Exercise | F | 32.82 | 796 | 26,125 | 166,758 | 167.6 K to 166.8 K (-0.48 %) |
Mar 10 2021 | BVF | Bausch Health Comp ... | ACKERMANN CHRISTINA | EVP AND GENERAL COU ... | Option Exercise | M | 0.00 | 8,455 | 0 | 0 | |
Mar 10 2021 | BVF | Bausch Health Comp ... | ACKERMANN CHRISTINA | EVP AND GENERAL COU ... | Payment of Exercise | F | 32.97 | 21,960 | 724,021 | 167,554 | 189.5 K to 167.6 K (-11.59 %) |
Mar 10 2021 | BVF | Bausch Health Comp ... | ACKERMANN CHRISTINA | EVP AND GENERAL COU ... | Grant | A | 0.00 | 25,980 | 0 | 189,514 | 163.5 K to 189.5 K (+15.89 %) |
Mar 10 2021 | BVF | Bausch Health Comp ... | ACKERMANN CHRISTINA | EVP AND GENERAL COU ... | Buy | M | 0.00 | 8,455 | 0 | 163,534 | 155.1 K to 163.5 K (+5.45 %) |
Mar 05 2021 | BVF | Bausch Health Comp ... | ACKERMANN CHRISTINA | EVP AND GENERAL COU ... | Option Exercise | A | 32.56 | 52,392 | 1,705,884 | 52,392 | |
Mar 05 2021 | BVF | Bausch Health Comp ... | ACKERMANN CHRISTINA | EVP AND GENERAL COU ... | Grant | A | 0.00 | 36,250 | 0 | 155,079 | 118.8 K to 155.1 K (+30.51 %) |
Aug 31 2020 | BVF | Bausch Health Comp ... | ACKERMANN CHRISTINA | EVP AND GENERAL COU ... | Grant | A | 0.00 | 28,171 | 0 | 124,196 | 96 K to 124.2 K (+29.34 %) |
Aug 31 2020 | BVF | Bausch Health Comp ... | ACKERMANN CHRISTINA | EVP AND GENERAL COU ... | Grant | A | 0.00 | 28,171 | 0 | 124,196 | 96 K to 124.2 K (+29.34 %) |
Mar 11 2020 | BVF | Bausch Health Comp ... | ACKERMANN CHRISTINA | EVP AND GENERAL COU ... | Grant | A | 0.00 | 4,390 | 0 | 96,025 | 91.6 K to 96 K (+4.79 %) |
Mar 11 2020 | BVF | Bausch Health Comp ... | ACKERMANN CHRISTINA | EVP AND GENERAL COU ... | Buy | P | 18.25 | 4,390 | 80,106 | 91,635 | 87.2 K to 91.6 K (+5.03 %) |
Mar 11 2020 | BVF | Bausch Health Comp ... | ACKERMANN CHRISTINA | EVP AND GENERAL COU ... | Payment of Exercise | F | 20.96 | 3,343 | 70,069 | 87,245 | 90.6 K to 87.2 K (-3.69 %) |
Mar 03 2020 | BVF | Bausch Health Comp ... | ACKERMANN CHRISTINA | EVP AND GENERAL COU ... | Payment of Exercise | F | 24.44 | 3,779 | 92,359 | 90,588 | 94.4 K to 90.6 K (-4.00 %) |
Mar 03 2020 | BVF | Bausch Health Comp ... | ACKERMANN CHRISTINA | EVP AND GENERAL COU ... | Payment of Exercise | F | 24.44 | 3,779 | 92,359 | 90,588 | 94.4 K to 90.6 K (-4.00 %) |
Feb 28 2020 | BVF | Bausch Health Comp ... | ACKERMANN CHRISTINA | EVP AND GENERAL COU ... | Option Exercise | A | 24.77 | 81,873 | 2,027,994 | 81,873 | |
Feb 28 2020 | BVF | Bausch Health Comp ... | ACKERMANN CHRISTINA | EVP AND GENERAL COU ... | Grant | A | 0.00 | 19,449 | 0 | 94,367 | 74.9 K to 94.4 K (+25.96 %) |
Feb 21 2020 | BVF | Bausch Health Comp ... | ACKERMANN CHRISTINA | EVP AND GENERAL COU ... | Option Exercise | M | 0.00 | 7,864 | 0 | 0 | |
Feb 21 2020 | BVF | Bausch Health Comp ... | ACKERMANN CHRISTINA | EVP AND GENERAL COU ... | Payment of Exercise | F | 26.46 | 22,378 | 592,122 | 59,190 | 81.6 K to 59.2 K (-27.43 %) |
Feb 21 2020 | BVF | Bausch Health Comp ... | ACKERMANN CHRISTINA | EVP AND GENERAL COU ... | Grant | A | 0.00 | 42,267 | 0 | 81,568 | 39.3 K to 81.6 K (+107.55 %) |
Feb 21 2020 | BVF | Bausch Health Comp ... | ACKERMANN CHRISTINA | EVP AND GENERAL COU ... | Sell | M | 0.00 | 7,864 | 0 | 39,301 | 47.2 K to 39.3 K (-16.67 %) |
Jan 09 2020 | BVF | Bausch Health Comp ... | ACKERMANN CHRISTINA | EVP AND GENERAL COU ... | Payment of Exercise | F | 29.42 | 3,360 | 98,851 | 47,165 | 50.5 K to 47.2 K (-6.65 %) |
Aug 13 2019 | BVF | Bausch Health Comp ... | ACKERMANN CHRISTINA | EVP AND GENERAL COU ... | Sell | S | 22.45 | 3,418 | 76,726 | 50,525 | 53.9 K to 50.5 K (-6.34 %) |
Aug 13 2019 | BVF | Bausch Health Comp ... | ACKERMANN CHRISTINA | EVP AND GENERAL COU ... | Payment of Exercise | F | 22.39 | 7,779 | 174,172 | 53,943 | 61.7 K to 53.9 K (-12.60 %) |
Jul 15 2019 | BVF | Bausch Health Comp ... | ACKERMANN CHRISTINA | EVP AND GENERAL COU ... | Sell | S | 24.81 | 3,968 | 98,446 | 61,722 | 65.7 K to 61.7 K (-6.04 %) |
Mar 12 2019 | BVF | Bausch Health Comp ... | ACKERMANN CHRISTINA | EVP AND GENERAL COU ... | Payment of Exercise | F | 23.56 | 3,630 | 85,523 | 65,690 | 69.3 K to 65.7 K (-5.24 %) |
Jan 10 2019 | BVF | Bausch Health Comp ... | ACKERMANN CHRISTINA | EVP AND GENERAL COU ... | Payment of Exercise | F | 21.25 | 3,446 | 73,228 | 48,010 | 51.5 K to 48 K (-6.70 %) |
Oct 17 2018 | BVF | Bausch Health Comp ... | ACKERMANN CHRISTINA | EVP AND GENERAL COU ... | Sell | S | 25.50 | 4,542 | 115,821 | 51,456 | 56 K to 51.5 K (-8.11 %) |
Oct 17 2018 | BVF | Bausch Health Comp ... | ACKERMANN CHRISTINA | EVP AND GENERAL COU ... | Sell | S | 24.83 | 15,404 | 382,481 | 55,998 | 71.4 K to 56 K (-21.57 %) |
Aug 13 2018 | BVF | Bausch Health Comp ... | ACKERMANN CHRISTINA | EVP AND GENERAL COU ... | Payment of Exercise | F | 23.52 | 7,779 | 182,962 | 71,402 | 79.2 K to 71.4 K (-9.82 %) |
Mar 09 2018 | BVF | Valeant Pharmaceut ... | ACKERMANN CHRISTINA | EVP AND GENERAL COU ... | Option Exercise | A | 0.00 | 13,638 | 0 | 13,638 | |
Mar 09 2018 | BVF | Valeant Pharmaceut ... | ACKERMANN CHRISTINA | EVP AND GENERAL COU ... | Option Exercise | A | 15.32 | 60,853 | 932,268 | 60,853 | |
Mar 09 2018 | BVF | Valeant Pharmaceut ... | ACKERMANN CHRISTINA | EVP AND GENERAL COU ... | Grant | A | 0.00 | 20,457 | 0 | 79,181 | 58.7 K to 79.2 K (+34.84 %) |
Jan 09 2018 | BVF | Valeant Pharmaceut ... | ACKERMANN CHRISTINA | EVP AND GENERAL COU ... | Payment of Exercise | F | 23.85 | 3,649 | 87,029 | 58,724 | 62.4 K to 58.7 K (-5.85 %) |
Aug 11 2017 | BVF | Valeant Pharmaceut ... | ACKERMANN CHRISTINA | EVP AND GENERAL COU ... | Payment of Exercise | F | 15.37 | 6,046 | 92,927 | 62,373 | 68.4 K to 62.4 K (-8.84 %) |
Mar 03 2017 | BVF | Valeant Pharmaceut ... | ACKERMANN CHRISTINA | EVP AND GENERAL COU ... | Option Exercise | A | 14.38 | 60,345 | 867,761 | 60,345 | |
Jan 10 2017 | BVF | Valeant Pharmaceut ... | ACKERMANN CHRISTINA | EVP and General Cou ... | Option Exercise | A | 0.00 | 16,384 | 0 | 16,384 | |
Jan 10 2017 | BVF | Valeant Pharmaceut ... | ACKERMANN CHRISTINA | EVP and General Cou ... | Grant | A | 0.00 | 24,575 | 0 | 68,419 | 43.8 K to 68.4 K (+56.05 %) |
Aug 12 2016 | BVF | Valeant Pharmaceut ... | ACKERMANN CHRISTINA | EVP and General Cou ... | Option Exercise | A | 27.32 | 39,469 | 1,078,293 | 39,469 | |
Aug 10 2016 | BVF | Valeant Pharmaceut ... | ACKERMANN CHRISTINA | EVP and General Cou ... | Grant | A | 0.00 | 122,762 | 0 | 122,762 | 0 to 122.8 K |
Page: 1